Mazdutide
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Innovent · Phase 1 · Completed · Enrollment 48
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| warfarin+atorvastatin+IBI362 | n/r | n/r | n/r | n/r |
| metformin+digoxin+IBI362 | n/r | n/r | n/r | n/r |
Not shown
- warfarin+atorvastatin+IBI362: endpoint not reported
- metformin+digoxin+IBI362: endpoint not reported